ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-Presentation.

Molecules · 2019 · PMC6540027 · PMID 31083610

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

NPs targeted by anti-DC-SIGN antibody showed a trend of enhancing IL-8 and IL-12 production when compared to NPs targeted by ICAM3-Fc ( Figure 3 E).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.